Junli He bought $21k of HRGN
CEO at Harvard Apparatus Regenerative Technology, Inc.. 11,225 shares at an average of $1.85, traded Sep 2, 2025, filed Sep 24, 2025.
Score components
- +25RoleCEO
- 0Trade size$21k at market
- 0Relative to holdingsHoldings up 4.2%
- +8Price context70% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-25-029783, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2025 | POpen-market purchase Common Stock | +11,225 | $1.85 | $21k | 277,275 | Sep 24, 2025 |
Related signals
Other insiders at Harvard Apparatus Regenerative Technology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $394k 368,630 shares | +38% | |
| 38Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $5,100 3,000 shares | +1% | |
| 33Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $594 300 shares | +0% | |
| 33Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $6,966 4,050 shares | +2% | |
| 20Weak | HRGNbuy Harvard Apparatus Regenerative Technology, Inc. | Junli He CEO | $6,598 2,299 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.